NGF/TRKA Decrease miR-145-5p Levels in Epithelial Ovarian Cancer Cells

Nerve Growth Factor (NGF) and its high-affinity receptor tropomyosin receptor kinase A (TRKA) increase their expression during the progression of epithelial ovarian cancer (EOC), promoting cell proliferation and angiogenesis through several oncogenic proteins, such as c-MYC and vascular endothelial...

Full description

Bibliographic Details
Main Authors: Maritza P. Garrido, Ignacio Torres, Alba Avila, Jonás Chnaiderman, Manuel Valenzuela-Valderrama, José Aramburo, Lorena Oróstica, Eduardo Durán-Jara, Lorena Lobos-Gonzalez, Carmen Romero
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/20/7657
_version_ 1797550785237614592
author Maritza P. Garrido
Ignacio Torres
Alba Avila
Jonás Chnaiderman
Manuel Valenzuela-Valderrama
José Aramburo
Lorena Oróstica
Eduardo Durán-Jara
Lorena Lobos-Gonzalez
Carmen Romero
author_facet Maritza P. Garrido
Ignacio Torres
Alba Avila
Jonás Chnaiderman
Manuel Valenzuela-Valderrama
José Aramburo
Lorena Oróstica
Eduardo Durán-Jara
Lorena Lobos-Gonzalez
Carmen Romero
author_sort Maritza P. Garrido
collection DOAJ
description Nerve Growth Factor (NGF) and its high-affinity receptor tropomyosin receptor kinase A (TRKA) increase their expression during the progression of epithelial ovarian cancer (EOC), promoting cell proliferation and angiogenesis through several oncogenic proteins, such as c-MYC and vascular endothelial growth factor (VEGF). The expression of these proteins is controlled by microRNAs (miRs), such as miR-145, whose dysregulation has been related to cancer. The aims of this work were to evaluate in EOC cells whether NGF/TRKA decreases miR-145 levels, and the effect of miR-145 upregulation. The levels of miR-145-5p were assessed by qPCR in ovarian biopsies and ovarian cell lines (human ovarian surface epithelial cells (HOSE), A2780 and SKOV3) stimulated with NGF. Overexpression of miR-145 in ovarian cells was used to evaluate cell proliferation, migration, invasion, c-MYC and VEGF protein levels, as well as tumor formation and metastasis in vivo. In EOC samples, miR-145-5p levels were lower than in epithelial ovarian tumors. Overexpression of miR-145 decreased cell proliferation, migration and invasion of EOC cells, changes that were concomitant with the decrease in c-MYC and VEGF protein levels. We observed decreased tumor formation and suppressed metastasis behavior in mice injected with EOC cells that overexpressed miR-145. As expected, ovarian cell lines stimulated with NGF diminished miR-145-5p transcription and abundance. These results suggest that the tumoral effects of NGF/TRKA depend on the regulation of miR-145-5p levels in EOC cells, and that its upregulation could be used as a possible therapeutic strategy for EOC.
first_indexed 2024-03-10T15:34:21Z
format Article
id doaj.art-4947c31d9dec4b11b37eb7ea92e29cf3
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T15:34:21Z
publishDate 2020-10-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-4947c31d9dec4b11b37eb7ea92e29cf32023-11-20T17:20:59ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-10-012120765710.3390/ijms21207657NGF/TRKA Decrease miR-145-5p Levels in Epithelial Ovarian Cancer CellsMaritza P. Garrido0Ignacio Torres1Alba Avila2Jonás Chnaiderman3Manuel Valenzuela-Valderrama4José Aramburo5Lorena Oróstica6Eduardo Durán-Jara7Lorena Lobos-Gonzalez8Carmen Romero9Laboratorio de Endocrinología y Biología de la Reproducción, Hospital Clínico Universidad de Chile, Santiago 8380456, ChileLaboratorio de Endocrinología y Biología de la Reproducción, Hospital Clínico Universidad de Chile, Santiago 8380456, ChileCentro de Medicina Regenerativa, Facultad de Medicina, Clínica Alemana-Universidad del Desarrollo, Santiago 7710162, ChilePrograma de Virología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago 8380453, ChileLaboratorio de Microbiología Celular. Instituto de Investigación e Innovación en Salud. Facultad de Ciencias de la Salud, Universidad Central de Chile, Santiago 8320000, ChileLaboratorio de Endocrinología y Biología de la Reproducción, Hospital Clínico Universidad de Chile, Santiago 8380456, ChileCentro de Investigación Biomédica (CIB), Facultad de Medicina, Universidad Diego Portales, Santiago 8370007, ChileCentro de Medicina Regenerativa, Facultad de Medicina, Clínica Alemana-Universidad del Desarrollo, Santiago 7710162, ChileCentro de Medicina Regenerativa, Facultad de Medicina, Clínica Alemana-Universidad del Desarrollo, Santiago 7710162, ChileLaboratorio de Endocrinología y Biología de la Reproducción, Hospital Clínico Universidad de Chile, Santiago 8380456, ChileNerve Growth Factor (NGF) and its high-affinity receptor tropomyosin receptor kinase A (TRKA) increase their expression during the progression of epithelial ovarian cancer (EOC), promoting cell proliferation and angiogenesis through several oncogenic proteins, such as c-MYC and vascular endothelial growth factor (VEGF). The expression of these proteins is controlled by microRNAs (miRs), such as miR-145, whose dysregulation has been related to cancer. The aims of this work were to evaluate in EOC cells whether NGF/TRKA decreases miR-145 levels, and the effect of miR-145 upregulation. The levels of miR-145-5p were assessed by qPCR in ovarian biopsies and ovarian cell lines (human ovarian surface epithelial cells (HOSE), A2780 and SKOV3) stimulated with NGF. Overexpression of miR-145 in ovarian cells was used to evaluate cell proliferation, migration, invasion, c-MYC and VEGF protein levels, as well as tumor formation and metastasis in vivo. In EOC samples, miR-145-5p levels were lower than in epithelial ovarian tumors. Overexpression of miR-145 decreased cell proliferation, migration and invasion of EOC cells, changes that were concomitant with the decrease in c-MYC and VEGF protein levels. We observed decreased tumor formation and suppressed metastasis behavior in mice injected with EOC cells that overexpressed miR-145. As expected, ovarian cell lines stimulated with NGF diminished miR-145-5p transcription and abundance. These results suggest that the tumoral effects of NGF/TRKA depend on the regulation of miR-145-5p levels in EOC cells, and that its upregulation could be used as a possible therapeutic strategy for EOC.https://www.mdpi.com/1422-0067/21/20/7657microRNA-145NGFTRKAepithelial ovarian cancerc-MYCVEGF
spellingShingle Maritza P. Garrido
Ignacio Torres
Alba Avila
Jonás Chnaiderman
Manuel Valenzuela-Valderrama
José Aramburo
Lorena Oróstica
Eduardo Durán-Jara
Lorena Lobos-Gonzalez
Carmen Romero
NGF/TRKA Decrease miR-145-5p Levels in Epithelial Ovarian Cancer Cells
International Journal of Molecular Sciences
microRNA-145
NGF
TRKA
epithelial ovarian cancer
c-MYC
VEGF
title NGF/TRKA Decrease miR-145-5p Levels in Epithelial Ovarian Cancer Cells
title_full NGF/TRKA Decrease miR-145-5p Levels in Epithelial Ovarian Cancer Cells
title_fullStr NGF/TRKA Decrease miR-145-5p Levels in Epithelial Ovarian Cancer Cells
title_full_unstemmed NGF/TRKA Decrease miR-145-5p Levels in Epithelial Ovarian Cancer Cells
title_short NGF/TRKA Decrease miR-145-5p Levels in Epithelial Ovarian Cancer Cells
title_sort ngf trka decrease mir 145 5p levels in epithelial ovarian cancer cells
topic microRNA-145
NGF
TRKA
epithelial ovarian cancer
c-MYC
VEGF
url https://www.mdpi.com/1422-0067/21/20/7657
work_keys_str_mv AT maritzapgarrido ngftrkadecreasemir1455plevelsinepithelialovariancancercells
AT ignaciotorres ngftrkadecreasemir1455plevelsinepithelialovariancancercells
AT albaavila ngftrkadecreasemir1455plevelsinepithelialovariancancercells
AT jonaschnaiderman ngftrkadecreasemir1455plevelsinepithelialovariancancercells
AT manuelvalenzuelavalderrama ngftrkadecreasemir1455plevelsinepithelialovariancancercells
AT josearamburo ngftrkadecreasemir1455plevelsinepithelialovariancancercells
AT lorenaorostica ngftrkadecreasemir1455plevelsinepithelialovariancancercells
AT eduardoduranjara ngftrkadecreasemir1455plevelsinepithelialovariancancercells
AT lorenalobosgonzalez ngftrkadecreasemir1455plevelsinepithelialovariancancercells
AT carmenromero ngftrkadecreasemir1455plevelsinepithelialovariancancercells